Other results showed a substantial decrease in serum levels of prostate-specific antigen (PSA), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in men with prostate cancer after short-term treatment with EGCG (Polyphenon E), with no raise in liver enzymes. Here, VEGFA is linked to prostate carcinoma.